The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet
Open accessAbstract
Purpose: To review and update the European LeukemiaNet (ELN) recommendations for the management of chronic myeloid leukemia with imatinib and second-generation tyrosine kinase inhibitors (TKIs), including monitoring, response definition, and first- and second-line therapy. Methods: These recommendations are based on a critical and comprehensive review of the relevant papers up to February 2009 and the results of four consensus conferences held by the panel of experts appointed by ELN in 2008. Results: Cytogenetic monitoring was required at 3, 6, 12, and 18 months. Molecular monitoring was required every 3 months. On the basis of the degree and the timing of hematologic, cytogenetic, and molecular results, the response to first-line imatinib was defined as optimal, suboptimal, or failure, and the response to second-generation TKIs was defined as suboptimal or failure. Conclusion: Initial treatment was confirmed as imatinib 400 mg daily. Imatinib should be continued indefinitely in optimal responders. Suboptimal responders may continue on imatinb, at the same or higher dose, or may be eligible for investigational therapy with second-generation TKIs. In instances of imatinib failure, second-generation TKIs are recommended, followed by allogeneic hematopoietic stem-cell transplantation only in instances of failure and, sometimes, suboptimal response, depending on transplantation risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
Self-citationO'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Self-citationFive-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O'Brien, S. G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M. W. N., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,488
Self-citationEffects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
Kolb, H., Schattenberg, A., Goldman, J., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., & Niederwieser, D. (1995) · Blood · doi:10.1182/blood.v86.5.2041.bloodjournal8652041 · Cited by 1,934
Self-citationOverriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Shah, N. P., Tran, C., Lee, F. Y., Chen, P., Norris, D., & Sawyers, C. L. (2004) · Science · doi:10.1126/science.1099480 · Cited by 1,796
Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias
Talpaz, M., Shah, N. P., Kantarjian, H., Donato, N., Nicoll, J., Paquette, R., Cortes, J., O'Brien, S., Nicaise, C., Bleickardt, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055229 · Cited by 1,760
Self-citationShah, N. P., Nicoll, J. M., Nagar, B., Gorre, M. E., Paquette, R. L., Kuriyan, J., & Sawyers, C. L. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00096-x · Cited by 1,612
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl
Weisberg, E., Manley, P. W., Breitenstein, W., Brüggen, J., Cowan-Jacob, S. W., Ray, A., Huntly, B., Fabbro, D., Fendrich, G., Hall-Meyers, E., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.007 · Cited by 1,492
A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
Klein, A. D., Kessel, A. G. V., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heisterkamp, N., Groffen, J., & Stephenson, J. R. (1982) · Nature · doi:10.1038/300765a0 · Cited by 1,378
Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL
Kantarjian, H., Giles, F., Wunderle, L., Bhalla, K., O'Brien, S., Wassmann, B., Tanaka, C., Manley, P., Rae, P., Mietlowski, W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055104 · Cited by 1,344
Self-citationNeonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., & Mulligan, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90011-m · Cited by 1,281
Baccarani, M. (2006) · Blood · doi:10.1182/blood-2006-02-005686 · Cited by 1,277
Self-citationHughes, T. P., Kaeda, J., Branford, S., Rudzki, Z., Hochhaus, A., Hensley, M. L., Gathmann, I., Bolton, A. E., van Hoomissen, I. C., Goldman, J. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030513 · Cited by 1,218
Self-citationPrognostic discrimination in "good-risk" chronic granulocytic leukemia
Sokal, J., Cox, E., Baccarani, M., Tura, S., Gomez, G., Robertson, J., Tso, C., Braun, T., Clarkson, B., & Cervantes, F. (1984) · Blood · doi:10.1182/blood.v63.4.789.789 · Cited by 1,214
Self-citationHughes, T. (2006) · Blood · doi:10.1182/blood-2006-01-0092 · Cited by 1,199
Self-citationEditorial: Some Speculations on the Myeloproliferative Syndromes
DAMESHEK, W. (1951) · Blood · doi:10.1182/blood.v6.4.372.372 · Cited by 1,082
O'Hare, T., Walters, D. K., Stoffregen, E. P., Jia, T., Manley, P. W., Mestan, J., Cowan-Jacob, S. W., Lee, F. Y., Heinrich, M. C., Deininger, M. W. N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0259 · Cited by 1,036
Self-citationTalpaz, M. (2002) · Blood · doi:10.1182/blood.v99.6.1928 · Cited by 1,019
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy
Hochhaus, A., Kreil, S., Corbin, A., La Rosée, P., Müller, M., Lahaye, T., Hanfstein, B., Schoch, C., Cross, N., Berger, U., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402741 · Cited by 906
Self-citationHochhaus, A., O'Brien, S. G., Guilhot, F., Druker, B. J., Branford, S., Foroni, L., Goldman, J. M., Müller, M. C., Radich, J. P., Rudoltz, M., et al. (2009) · Leukemia · doi:10.1038/leu.2009.38 · Cited by 856
Self-citationImatinib Mesylate — A New Oral Targeted Therapy
Savage, D. G., & Antman, K. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmra013339 · Cited by 844
Hasford, J., Pfirrmann, M., Hehlmann, R., Allan, N. C., Baccarani, M., Kluin-Nelemans, J. C., Alimena, G., Steegmann, J. L., & Ansari, H. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.11.850 · Cited by 819
Self-citationBranford, S., Rudzki, Z., Walsh, S., Parkinson, I., Grigg, A., Szer, J., Taylor, K., Herrmann, R., Seymour, J. F., Arthur, C., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2896 · Cited by 765
Self-citationKantarjian, H. M., Giles, F., Gattermann, N., Bhalla, K., Alimena, G., Palandri, F., Ossenkoppele, G. J., Nicolini, F.-E., O'Brien, S. G., Litzow, M., et al. (2007) · Blood · doi:10.1182/blood-2007-03-080689 · Cited by 746
Self-citationMolecular biology of bcr-abl1–positive chronic myeloid leukemia
Quintás-Cardama, A., & Cortes, J. (2009) · Blood · doi:10.1182/blood-2008-03-144790 · Cited by 745
Self-citationTokarski, J. S., Newitt, J. A., Chang, C. Y. J., Cheng, J. D., Wittekind, M., Kiefer, S. E., Kish, K., Lee, F. Y. F., Borzillerri, R., Lombardo, L. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4187 · Cited by 700
Translation of the Philadelphia chromosome into therapy for CML
Druker, B. J. (2008) · Blood · doi:10.1182/blood-2008-07-077958 · Cited by 668
Clinical Pharmacokinetics of Imatinib
Peng, B., Lloyd, P., & Schran, H. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544090-00001 · Cited by 665
Branford, S., Rudzki, Z., Walsh, S., Grigg, A., Arthur, C., Taylor, K., Herrmann, R., Lynch, K. P., & Hughes, T. P. (2002) · Blood · doi:10.1182/blood.v99.9.3472 · Cited by 649
Self-citationGratwohl, A., Hermans, J., Goldman, J., Arcese, W., Carreras, E., Devergie, A., Frassoni, F., Gahrton, G., Kolb, H., Niederwieser, D., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03030-x · Cited by 646
Self-citationLarson, R. A., Druker, B. J., Guilhot, F., O'Brien, S. G., Riviere, G. J., Krahnke, T., Gathmann, I., & Wang, Y. (2008) · Blood · doi:10.1182/blood-2007-10-116475 · Cited by 643
Self-citationPart I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia
Apperley, J. F. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70342-x · Cited by 643
Self-citationO'Hare, T., Eide, C. A., & Deininger, M. W. N. (2007) · Blood · doi:10.1182/blood-2007-03-066936 · Cited by 641
Self-citationMechanisms of Autoinhibition and STI-571/Imatinib Resistance Revealed by Mutagenesis of BCR-ABL
Azam, M., Latek, R. R., & Daley, G. Q. (2003) · Cell · doi:10.1016/s0092-8674(03)00190-9 · Cited by 613
Hochhaus, A., Kantarjian, H. M., Baccarani, M., Lipton, J. H., Apperley, J. F., Druker, B. J., Facon, T., Goldberg, S. L., Cervantes, F., Niederwieser, D., et al. (2007) · Blood · doi:10.1182/blood-2006-09-047266 · Cited by 609
Self-citationGene expression changes associated with progression and response in chronic myeloid leukemia
Radich, J. P., Dai, H., Mao, M., Oehler, V., Schelter, J., Druker, B., Sawyers, C., Shah, N., Stock, W., Willman, C. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510423103 · Cited by 583
Self-citationde Lavallade, H., Apperley, J. F., Khorashad, J. S., Milojkovic, D., Reid, A. G., Bua, M., Szydlo, R., Olavarria, E., Kaeda, J., Goldman, J. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8154 · Cited by 551
Self-citationRousselot, P., Huguet, F., Rea, D., Legros, L., Cayuela, J. M., Maarek, O., Blanchet, O., Marit, G., Gluckman, E., Reiffers, J., et al. (2007) · Blood · doi:10.1182/blood-2006-03-011239 · Cited by 538
Soverini, S., Colarossi, S., Gnani, A., Rosti, G., Castagnetti, F., Poerio, A., Iacobucci, I., Amabile, M., Abruzzese, E., Orlandi, E., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1516 · Cited by 511
Self-citationHehlmann, R., Hochhaus, A., & Baccarani, M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61165-9 · Cited by 501
Self-citationShah, N. P., Kantarjian, H. M., Kim, D.-W., Réa, D., Dorlhiac-Llacer, P. E., Milone, J. H., Vela-Ojeda, J., Silver, R. T., Khoury, H. J., Charbonnier, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9260 · Cited by 489
Self-citationSilver, R. T., Woolf, S. H., Hehlmann, R., Appelbaum, F. R., Anderson, J., Bennett, C., Goldman, J. M., Guilhot, F., Kantarjian, H. M., Lichtin, A. E., et al. (1999) · PubMed · Cited by 463
Self-citationHehlmann, R., Heimpel, H., Hasford, J., Kolb, H., Pralle, H., Hossfeld, D., Queisser, W., Loffler, H., Hochhaus, A., & Heinze, B. (1994) · Blood · doi:10.1182/blood.v84.12.4064.bloodjournal84124064 · Cited by 448
Self-citationPractical Management of Patients With Chronic Myeloid Leukemia Receiving Imatinib
Deininger, M. W. N., O’Brien, S. G., Ford, J. M., & Druker, B. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.143 · Cited by 402
Self-citationActivity of Bosutinib, Dasatinib, and Nilotinib Against 18 Imatinib-Resistant BCR/ABL Mutants
Redaelli, S., Piazza, R., Rostagno, R., Magistroni, V., Perini, P., Marega, M., Gambacorti-Passerini, C., & Boschelli, F. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8853 · Cited by 399
The effects of imatinib on pregnancy outcome
Pye, S. M., Cortes, J., Ault, P., Hatfield, A., Kantarjian, H., Pilot, R., Rosti, G., & Apperley, J. F. (2008) · Blood · doi:10.1182/blood-2007-10-114900 · Cited by 395
Self-citationBradeen, H. A., Eide, C. A., O'Hare, T., Johnson, K. J., Willis, S. G., Lee, F. Y., Druker, B. J., & Deininger, M. W. (2006) · Blood · doi:10.1182/blood-2006-02-004580 · Cited by 393
Self-citationBranford, S., Fletcher, L., Cross, N. C. P., Müller, M. C., Hochhaus, A., Kim, D.-W., Radich, J. P., Saglio, G., Pane, F., Kamel-Reid, S., et al. (2008) · Blood · doi:10.1182/blood-2008-04-150680 · Cited by 388
Self-citationJabbour, E., Kantarjian, H., Jones, D., Talpaz, M., Bekele, N., O'Brien, S., Zhou, X., Luthra, R., Garcia-Manero, G., Giles, F., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404318 · Cited by 386
Self-citationTalpaz, M., Kantarjian, H., Kurzrock, R., Trujillo, J. M., & Gutterman, J. U. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-7-532 · Cited by 382
Self-citationKantarjian, H., Pasquini, R., Hamerschlak, N., Rousselot, P., Holowiecki, J., Jootar, S., Robak, T., Khoroshko, N., Masszi, T., Skotnicki, A., et al. (2007) · Blood · doi:10.1182/blood-2006-11-056028 · Cited by 377
Self-citationPuttini, M., Coluccia, A. M. L., Boschelli, F., Cleris, L., Marchesi, E., Donella-Deana, A., Ahmed, S., Redaelli, S., Piazza, R., Magistroni, V., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1199 · Cited by 375
Hochhaus, A., Baccarani, M., Deininger, M., Apperley, J. F., Lipton, J. H., Goldberg, S. L., Corm, S., Shah, N. P., Cervantes, F., Silver, R. T., et al. (2008) · Leukemia · doi:10.1038/leu.2008.84 · Cited by 352
Self-citationMarin, D., Milojkovic, D., Olavarria, E., Khorashad, J. S., de Lavallade, H., Reid, A. G., Foroni, L., Rezvani, K., Bua, M., Dazzi, F., et al. (2008) · Blood · doi:10.1182/blood-2008-06-162388 · Cited by 328
Self-citationBurgess, M. R., Skaggs, B. J., Shah, N. P., Lee, F. Y., & Sawyers, C. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409770102 · Cited by 313
Chromosomal localization of human cellular homologues of two viral oncogenes
Heisterkamp, N., Groffen, J., Stephenson, J. R., Spurr, N. K., Goodfellow, P. N., Solomon, E., Carritt, B., & Bodmer, W. F. (1982) · Nature · doi:10.1038/299747a0 · Cited by 303
Willis, S. G., Lange, T., Demehri, S., Otto, S., Crossman, L., Niederwieser, D., Stoffregen, E. P., McWeeney, S., Kovacs, I., Park, B., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1036 · Cited by 302
Self-citationCortes, J., Jabbour, E., Kantarjian, H., Yin, C. C., Shan, J., O'Brien, S., Garcia-Manero, G., Giles, F., Breeden, M., Reeves, N., et al. (2007) · Blood · doi:10.1182/blood-2007-03-080838 · Cited by 296
Self-citationGratwohl, A. A., Brand, R., Apperley, J. F., Crawley, C. R., Ruutu, T., Corradini, P., Carreras, E., Devergié, A., Guglielmi, C., Kölb, H.-J., et al. (2006) · PubMed · Cited by 290
Self-citationCortes, J. E., Baccarani, M., Guilhot, F., Druker, B. J., Branford, S., Kim, D.-W., Pane, F., Pasquini, R., Goldberg, S. L., Kalaycio, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.3724 · Cited by 284
Self-citationALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKAEMIA
Speck, B., Bortin, M., Champlin, R., Goldman, J., Herzig, R., Mcglave, P., Messner, H., Weiner, R., & Rimm, A. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92179-2 · Cited by 259
Self-citationCorbin, A. S., Rosée, P. L., Stoffregen, E. P., Druker, B. J., & Deininger, M. W. (2003) · Blood · doi:10.1182/blood-2002-12-3659 · Cited by 258
Self-citationNew Insights into the Pathophysiology of Chronic Myeloid Leukemia and Imatinib Resistance
Kantarjian, H. M., Talpaz, M., Giles, F., O'Brien, S., & Cortes, J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-12-200612190-00008 · Cited by 256
Self-citationMcGlave, P. B., Shu, X. O., Wen, W., Anasetti, C., Nademanee, A., Champlin, R., Antin, J. H., Kernan, N. A., King, R., & Weisdorf, D. J. (2000) · Blood · doi:10.1182/blood.v95.7.2219 · Cited by 235
BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice
Voncken, J., Kaartinen, V, Pattengale, P., Germeraad, W., Groffen, J., & Heisterkamp, N. (1995) · Blood · doi:10.1182/blood.v86.12.4603.bloodjournal86124603 · Cited by 216
Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias
Shah, N. P., & Sawyers, C. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206942 · Cited by 216
Roy, L., Guilhot, J., Krahnke, T., Guerci-Bresler, A., Druker, B. J., Larson, R. A., O'Brien, S., So, C., Massimini, G., & Guilhot, F. (2006) · Blood · doi:10.1182/blood-2006-02-001495 · Cited by 216
Self-citationHow I treat chronic myeloid leukemia in the imatinib era
Goldman, J. M. (2007) · Blood · doi:10.1182/blood-2007-04-038943 · Cited by 212
Self-citationKantarjian, H. M., Talpaz, M., O'Brien, S., Jones, D., Giles, F., Garcia-Manero, G., Faderl, S., Ravandi, F., Rios, M. B., Shan, J., et al. (2006) · Blood · doi:10.1182/blood-2006-02-004325 · Cited by 208
Self-citationNicolini, F. E., Corm, S., Lê, Q.-H., Sorel, N., Hayette, S., Bories, D., Leguay, T., Roy, L., Giraudier, S., Tulliez, M., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404236 · Cited by 207
Self-citationGolemovic, M., Verstovsek, S., Giles, F., Cortes, J., Manshouri, T., Manley, P. W., Mestan, J., Dugan, M., Alland, L., Griffin, J. D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2601 · Cited by 203
Self-citationProposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia
Kantarjian, H. M., Keating, M. J., Smith, T. L., Talpaz, M., & McCredie, K. B. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90119-x · Cited by 199
Self-citationCell Cycle—Regulated Binding of c-Abl Tyrosine Kinase to DNA
Kipreos, E. T., & Wang, J. Y. J. (1992) · Science · doi:10.1126/science.256.5055.382 · Cited by 197
Verfaillie, C., Miller, W., Boylan, K., & McGlave, P. (1992) · Blood · doi:10.1182/blood.v79.4.1003.1003 · Cited by 196
Baccarani, M., Rosti, G., Castagnetti, F., Haznedaroglu, I., Porkka, K., Abruzzese, E., Alimena, G., Ehrencrona, H., Hjorth-Hansen, H., Kairisto, V., et al. (2009) · Blood · doi:10.1182/blood-2008-12-191254 · Cited by 195
Self-citationTumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.
Sánchez-García, I., & Grütz, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5287 · Cited by 192
Soverini, S., Colarossi, S., Gnani, A., Castagnetti, F., Rosti, G., Bosi, C., Paolini, S., Rondoni, M., Piccaluga, P. P., Palandri, F., et al. (2007) · Haematologica · doi:10.3324/haematol.10822 · Cited by 189
Self-citationThe Cytogenetic Scenario of Chronic Myeloid Leukemia
Mitelman, F. (1993) · Leukemia & Lymphoma · doi:10.3109/10428199309047856 · Cited by 184
Khorashad, J. S., de Lavallade, H., Apperley, J. F., Milojkovic, D., Reid, A. G., Bua, M., Szydlo, R., Olavarria, E., Kaeda, J., Goldman, J. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.9953 · Cited by 183
Self-citationHughes, T. P., Branford, S., White, D. L., Reynolds, J., Koelmeyer, R., Seymour, J. F., Taylor, K., Arthur, C., Schwarer, A., Morton, J., et al. (2008) · Blood · doi:10.1182/blood-2008-06-161737 · Cited by 180
Self-citationTreatment of chronic myelogenous leukemia: current status and investigational options [see comments]
Kantarjian, H., O'Brien, S., Anderlini, P., & Talpaz, M. (1996) · Blood · doi:10.1182/blood.v87.8.3069.bloodjournal8783069 · Cited by 178
Self-citationIngestion, inhalation, and dermal exposures to chloroform and trichloroethene from tap water.
Weisel, C. P., & Jo, W. K. (1996) · Environmental Health Perspectives · doi:10.1289/ehp.9610448 · Cited by 177
O’Brien, S. G., Guilhot, F., Goldman, J. M., Hochhaus, A., Hughes, T. P., Radich, J. P., Rudoltz, M., Filian, J., Gathmann, I., Druker, B. J., et al. (2008) · Blood · doi:10.1182/blood.v112.11.186.186 · Cited by 172
Self-citationSacchi, S., Kantarjian, H., O'Brien, S., Cohen, P. R., Pierce, S., & Talpaz, M. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.9.2401 · Cited by 170
Self-citationRedondo-Muñóz, J., Ugarte-Berzal, E., Garcia-Marco, J. A., del Cerro, M. H., den Steen, P. E. V., Opdenakker, G., Terol, M. J., & García-Pardo, A. (2008) · Blood · doi:10.1182/blood-2007-08-109249 · Cited by 170
Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups
McGlave, P. B., De Fabritiis, P., Deisseroth, A., Goldman, J., Barnett, M., Reiffers, J., Simonsson, B., Carella, A., & Aeppli, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92589-5 · Cited by 169
Self-citationBaccarani, M., Rosti, G., de Vivo, A., Bonifazi, F., Russo, D., Martinelli, G., Testoni, N., Amabile, M., Fiacchini, M., Montefusco, E., et al. (2002) · Blood · doi:10.1182/blood.v99.5.1527 · Cited by 166
Self-citationChronic myelogenous leukemia: A review
Cortes, J. E., Talpaz, M., & Kantarjian, H. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00061-7 · Cited by 163
Self-citationDrug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia
Hehlmann, R., Berger, U., Pfirrmann, M., Heimpel, H., Hochhaus, A., Hasford, J., Kolb, H.-J., Lahaye, T., Maywald, O., Reiter, A., et al. (2007) · Blood · doi:10.1182/blood-2006-11-055186 · Cited by 161
Self-citationManley, P. W., Cowan-Jacob, S. W., & Mestan, J. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.07.040 · Cited by 160
Kantarjian, H., Schiffer, C., Jones, D., & Cortes, J. (2008) · Blood · doi:10.1182/blood-2007-09-110189 · Cited by 158
Self-citationJabbour, E. J., Kantarjian, H. M., Jones, D. M., Shan, J., O'Brien, S. M., Reddy, N., Wierda, W. G., Faderl, S. H., Garcia‐Manero, G., Verstovšek, S., et al. (2008) · Blood · doi:10.1182/blood-2008-04-154344 · Cited by 155
Self-citationKovitz, C. A., Kantarjian, H. M., Garcia‐Manero, G., Abruzzo, L. V., & Cortes, J. E. (2006) · Blood · doi:10.1182/blood-2006-04-017400 · Cited by 150
Self-citationKhorashad, J. S., Anand, M., Marin, D., Saunders, S., Al-Jabary, T., Iqbal, A., Margerison, S., Melo, J. V., Goldman, J. M., Apperley, J. F., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404137 · Cited by 149
Self-citationDiaz-Blanco, E., Bruns, I., Neumann, F., Fischer, J. C., Graef, T., Rosskopf, M., Brors, B., Pechtel, S., Bork, S., Koch, A., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404549 · Cited by 148
Jabbour, E. J., Kantarjian, H. M., Jones, D. M., Breeden, M., Garcia‐Manero, G., O'Brien, S. M., Ravandi, F., Borthakur, G. M., & Cortes, J. E. (2008) · Blood · doi:10.1182/blood-2007-11-123950 · Cited by 147
Self-citationJabbour, E. J., Kantarjian, H. M., Abruzzo, L. V., O'Brien, S. M., Garcia‐Manero, G., Verstovšek, S., Shan, J., Rios, M. B., & Cortes, J. E. (2007) · Blood · doi:10.1182/blood-2007-01-070045 · Cited by 146
Self-citationCurrent and emerging treatment options in chronic myeloid leukemia
Jabbour, E. J., Cortes, J. E., Giles, F. J., O'Brien, S. M., & Kantarjian, H. M. (2007) · Cancer · doi:10.1002/cncr.22661 · Cited by 135
Self-citationLee, S. J., Kukreja, M. K., Wang, T., Giralt, S. A., Szer, J., Arora, M., Woolfrey, A. E., Cervantes, F., Champlin, R. E., Gale, R. P., et al. (2008) · Blood · doi:10.1182/blood-2008-02-141689 · Cited by 133
Self-citationOehler, V. G., Gooley, T. A., Snyder, D., Johnston, L., Lin, A., Cummings, C. C., Chu, S., Bhatia, R., Forman, S. J., Negrin, R. S., et al. (2006) · Blood · doi:10.1182/blood-2006-06-031682 · Cited by 132
Self-citationDeininger, M. W., Cortes, J. E., Paquette, R. L., Park, B. S., Hochhaus, A., Baccarani, M., Stone, R. M., Fischer, T., Kantarjian, H. M., Niederwieser, D. W., et al. (2007) · Cancer · doi:10.1002/cncr.22936 · Cited by 132
Self-citationRay, A., Cowan‐Jacob, S. W., Manley, P. W., Mestan, J., & Griffin, J. D. (2007) · Blood · doi:10.1182/blood-2006-01-015347 · Cited by 128
Sneed, T. B., Kantarjian, H. M., Talpaz, M., O'Brien, S. M., Rios, M. B., Bekele, B. N., Zhou, X., Resta, D. J., Wierda, W., Faderl, S. H., et al. (2003) · Cancer · doi:10.1002/cncr.11863 · Cited by 127
Self-citationCortes, J. E., Kantarjian, H. M., Goldberg, S. L., Powell, B. L., Giles, F. J., Wetzler, M., Akard, L. P., Burke, J. M., Kerr, R. O., Saleh, M. N., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.3869 · Cited by 126
Self-citationPress, R. D., Galderisi, C., Yang, R., Rempfer, C., Willis, S. G., Mauro, M. J., Druker, B. J., & Deininger, M. W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1112 · Cited by 126
Self-citationSchmidli, H., Peng, B., Riviere, G., Capdeville, R., Hensley, M. L., Gathmann, I., Bolton, A. E., & Racine-Poon, A. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02372.x · Cited by 123
Zheng, C., Li, L., Haak, M., Brors, B., Frank, O., Giehl, M., Fabarius, A. C., Schatz, M. C., Weisser, A., Lorentz, C., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404227 · Cited by 121
Self-citationSoverini, S., Martinelli, G., Amabile, M., Poerio, A., Bianchini, M., Rosti, G., Pane, F., Saglio, G. N., Baccarani, M., the Italian Cooperative Study Group on Chronic Myeloid Leukemia (icsg-cml), et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.031112 · Cited by 120
Self-citationEfficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase
Kantarjian, H. M., Larson, R. A., Guilhot, F., O’Brien, S. G., Mone, M. D., Rudoltz, M. S., Krahnke, T., Cortes, J. E., Druker, B. J., & for the International Randomized Study of Interferon and STI571 (IRIS) Investigators (2009) · Cancer · doi:10.1002/cncr.24066 · Cited by 114
Self-citationIdentification of genes involved in imatinib resistance in CML: a gene-expression profiling approach
Villuendas, R., Steegmann, J. L., Pollán, M., Tracey, L., Granda, A., Fernández‐Ruiz, E., Casado, L., Martínez‐López, J., Martinez, P. B., Lombardía, L., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404197 · Cited by 111
Part II: Management of resistance to imatinib in chronic myeloid leukaemia
Apperley, J. F. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70379-0 · Cited by 111
Self-citationGene expression signature of primary imatinib-resistant chronic myeloid leukemia patients
Frank, O., Brors, B., Fabarius, A. C., Li, L., Haak, M., Merk, S., Schwindel, U., Zheng, C., Müller, M. C., Gretz, N., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404270 · Cited by 110
Self-citationDynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinib
Ernst, T., Erben, P., Muller, M. C., Paschka, P., Schenk, T., Hoffmann, J., Kreil, S., Rosée, P. G. L., Hehlmann, R., & Hochhaus, A. (2008) · Haematologica · doi:10.3324/haematol.11993 · Cited by 108
Self-citationMüller, M. C., Erben, P., Saglio, G. N., Gottardi, E. M., Nyvold, C. G., Schenk, T., Ernst, T., Lauber, S., Kruth, J., Hehlmann, R., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404983 · Cited by 107
Self-citationAlvarado, Y., Kantarjian, H. M., O'Brien, S. M., Faderl, S. H., Borthakur, G. M., Burger, J. A., Wierda, W. G., Garcia‐Manero, G., Shan, J., & Cortes, J. E. (2009) · Cancer · doi:10.1002/cncr.24418 · Cited by 106
Self-citationGale, R. P., Hehlmann, R., Zhang, M. J., Hasford, J., Goldman, J. M., Heimpel, H., Hochhaus, A., Klein, J. P., Kolb, H. J., McGlave, P. B., et al. (1998) · PubMed · Cited by 105
Self-citationLucas, C. M., Wang, L., Austin, G. M., et al. (2008) · Leukemia · doi:10.1038/leu.2008.225 · Cited by 101
15-deoxy-Δ12,14-PGJ2 enhances platelet production from megakaryocytes
O'Brien, J. J., Spinelli, S. L., Tober, J. M., Blumberg, N., Francis, C. W., Taubman, M. B., Palis, J., Seweryniak, K. E., Gertz, J. M., & Phipps, R. P. (2008) · Blood · doi:10.1182/blood-2008-05-158535 · Cited by 101
Monitoring treatment of chronic myeloid leukemia
Baccarani, M., Pane, F., & Saglio, G. N. (2008) · Haematologica · doi:10.3324/haematol.12588 · Cited by 99
Self-citationShtalrid, M., Talpaz, M., Kurzrock, R., Kantarjian, H., Trujillo, J. M., Gutterman, J. U., Yoffe, G., & Blick, M. B. (1988) · Blood · doi:10.1182/blood.v72.2.485.485 · Cited by 98
Self-citationMills, K., MacKenzie, E. D., & Birnie, G. (1988) · Blood · doi:10.1182/blood.v72.4.1237.1237 · Cited by 96
The karyotype of blastic crisis
Alimena, G., Cuia, M. R. D., Diverio, D., Gastaldi, R., & Nanni, M. (1987) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(87)90131-2 · Cited by 93
Tipping, A. J., Mahon, F., Zafirides, G., Lagarde, V., Goldman, J. M., & Melo, J. V. (2002) · Leukemia · doi:10.1038/sj.leu.2402775 · Cited by 91
Self-citationResistance to Targeted Therapy in Chronic Myelogenous Leukemia
Hochhaus, A., Erben, P., Ernst, T., & Mueller, M. (2007) · Seminars in Hematology · doi:10.1053/j.seminhematol.2006.12.002 · Cited by 84
Self-citationJones, D. M., Kamel‐Reid, S., Bahler, D. W., Dong, H. Y., Elenitoba‐Johnson, K. S. J., Press, R. D., Quigley, N. B., Rothberg, P. G., Sabath, D., Viswanatha, D. S., et al. (2008) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2009.080095 · Cited by 83
Selective induction of leukemia-associated fusion genes by high-dose ionizing radiation.
Deininger, M. W., Bose, S., Góra‐Tybor, J., Yan, X. H., Goldman, J. M., & Melo, J. V. (1998) · PubMed · Cited by 82
Self-citationTestoni, N., Marzocchi, G., Luatti, S., Amabile, M., Baldazzi, C., Stacchini, M., Nanni, M., Rege‐Cambrin, G., Giugliano, E., Giussani, U., et al. (2009) · Blood · doi:10.1182/blood-2009-07-229864 · Cited by 81
Self-citationJabbour, E. J., Kantarjian, H. M., Jones, D. M., Reddy, N., O'Brien, S. M., Garcia‐Manero, G., Burger, J. A., & Cortes, J. E. (2008) · Blood · doi:10.1182/blood-2008-04-149948 · Cited by 79
Self-citationSherbenou, D. W., Wong, M. J., Humayun, A., McGreevey, L. S., Harrell, P. M., Yang, R., Mauro, M. J., Heinrich, M. C., Press, R. D., Druker, B. J., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404554 · Cited by 79
Self-citationCastagnetti, F., Palandri, F., Amabile, M., Testoni, N., Luatti, S., Soverini, S., Iacobucci, I., Breccia, M., Cambrin, G. R., Stagno, F., et al. (2009) · Blood · doi:10.1182/blood-2007-08-103499 · Cited by 74
Self-citationNicolini, F. E., Hayette, S., Corm, S., Bachy, E., Bories, D., Tulliez, M., Guilhot, F., Legros, L., Maloisel, F., Kiladjian, J., et al. (2007) · Haematologica · doi:10.3324/haematol.11369 · Cited by 74
Self-citationTherapy-Related Chronic Myeloid Leukemia: An Epidemiological, Clinical and Pathogenetic Appraisal
Aguiar, R. C. T. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809058378 · Cited by 72
Detection of ABL kinase domain mutations with denaturing high-performance liquid chromatography
Deininger, M. W., McGreevey, L. S., Willis, S. G., Bainbridge, T., Druker, B. J., & Heinrich, M. C. (2004) · Leukemia · doi:10.1038/sj.leu.2403307 · Cited by 70
Self-citationDeininger, M. W. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5015 · Cited by 70
Self-citationKantarjian, H. M., Shan, J., Jones, D. M., O'Brien, S. M., Rios, M. B., Jabbour, E. J., & Cortes, J. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6999 · Cited by 68
Self-citationJabbour, E. J., Cortes, J. E., Kantarjian, H. M., Giralt, S., Andersson, B. S., Giles, F. J., Shpall, E. J., Kebriaei, P., Champlin, R. E., & de Lima, M. (2007) · Cancer · doi:10.1002/cncr.22778 · Cited by 64
Self-citationInokuchi, K., Inoue, T. K., Tojo, A., Futaki, M., Miyake, K., Yamada, T., Tanabe, Y., Ohki, I., Dan, K., & OZAWA, K. (1991) · Blood · doi:10.1182/blood.v78.12.3125.3125 · Cited by 64
Carella, A. M., Cunningham, I. B., Lerma, E., Dejana, A. M., Benvenuto, F., Podestà, M., Celesti, L., Chimirri, F., Abote, M., Vassallo, F., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1575 · Cited by 63
Cortes, J. E., O'Brien, S. M., Jabbour, E. J., Ferrajoli, A., Borthakur, G. M., Burger, J. A., Wierda, W. G., Garcia‐Manero, G., Thomas, M., Letvak, L. A., et al. (2007) · Blood · doi:10.1182/blood.v110.11.29.29 · Cited by 60
Self-citationMolecular monitoring in chronic myeloid leukemia
Jabbour, E. J., Cortes, J. E., & Kantarjian, H. M. (2008) · Cancer · doi:10.1002/cncr.23427 · Cited by 59
Self-citationTargeted therapy and the T315I mutation in Philadelphia-positive leukemias
Soverini, S., Iacobucci, I., Baccarani, M., & Martinelli, G. (2007) · Haematologica · doi:10.3324/haematol.11248 · Cited by 53
Self-citationCortes, J. E., Baccarani, M., Guilhot, F., Druker, B. J., Branford, S., Kim, D.-W., Pane, F., Rudoltz, M. S., Yu, R., Collins, L. R., et al. (2008) · Blood · doi:10.1182/blood.v112.11.335.335 · Cited by 53
Self-citationShimoni, A., Leiba, M., Schleuning, M., Martineau, G., Renaud, M., Koren‐Michowitz, M., Ribakovsky, E., le Coutre, P., Arnold, R., Guilhot, F., et al. (2008) · Leukemia · doi:10.1038/leu.2008.160 · Cited by 47
Self-citationVickers, M. A. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1751.x · Cited by 43
Hochhaus, A., Müller, M. C., Radich, J. P., Branford, S., Kantarjian, H. M., Hanfstein, B., Rousselot, P. H., Kim, D.-W., Lipton, J. H., Bleickardt, E. W., et al. (2009) · Leukemia · doi:10.1038/leu.2009.156 · Cited by 40
Self-citationPlosker, G. L., & Robinson, D. M. (2008) · Drugs · doi:10.2165/00003495-200868040-00005 · Cited by 40
Cortes, J. E., O'Brien, S. M., Ferrajoli, A., Borthakur, G., Burger, J., Wierda, W., García-Manero, G., Letvak, L. A., & Kantarjian, H. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.7016 · Cited by 34
Self-citationKim, D. H. (., Popradi, G., Sriharsha, L., Kamel‐Reid, S., Chang, H., Messner, H. A., & Lipton, J. H. (2008) · Cancer · doi:10.1002/cncr.23607 · Cited by 32
Fioretos, T. (2015) · Wiley eBooks · doi:10.1002/9781118795569.ch8 · Cited by 31
OPTIONS FOR THERAPY IN CHRONIC MYELOID LEUKAEMIA
Spencer, A. G., O’Brien, S. G., & Goldman, J. M. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05236.x · Cited by 29
Self-citationSaldanha, J., Silvy, M., Beaufils, N., Arlinghaus, R. B., Barbany, G., Branford, S., Cayuela, J., Cazzaniga, G., González, M., Grimwade, D. J., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404716 · Cited by 27
Self-citationGuilhot, F., Mahon, F., Guilhot, J., Huguet, F., Maloisel, F., Rousselot, P. H., Gardembas, M., Corm, S., Guerci‐Bresler, A., Vekhoff, A., et al. (2008) · Blood · doi:10.1182/blood.v112.11.183.183 · Cited by 18
Self-citationJabbour, E. J., & Kantarjian, H. M. (2007) · Seminars in Hematology · doi:10.1053/j.seminhematol.2006.12.001 · Cited by 15
Self-citationGardenghi, S., Marongiu, M. F., Muirhead, K., Ramos, P., Roy, C. N., Andrews, N. C., Nemeth, E., Follenzi, A., Rachmilewitz, E. A., Giardina, P. J., et al. (2008) · Blood · doi:10.1182/blood.v112.11.128.128 · Cited by 12
Soverini, S., Baccarani, M., Iacobucci, I., & Martinelli, G. (2007) · Clinical Leukemia · doi:10.3816/clk.2007.n.012 · Cited by 6
Self-citation
Cited by
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Baccarani, M., Deininger, M. W., Rosti, G., Hochhaus, A., Soverini, S., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Guilhot, F., et al. (2013) · Blood · doi:10.1182/blood-2013-05-501569 · Cited by 1,987
Self-citationNilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
Saglio, G., Kim, D.-W., Issaragrisil, S., le Coutre, P., Etienne, G., Lobo, C., Pasquini, R., Clark, R. E., Hochhaus, A., Hughes, T. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912614 · Cited by 1,678
Self-citationDasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Kantarjian, H., Shah, N. P., Hochhaus, A., Cortes, J., Shah, S., Ayala, M., Moiraghi, B., Shen, Z., Mayer, J., Pasquini, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002315 · Cited by 1,589
Self-citationEuropean LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Hochhaus, A., Baccarani, M., Silver, R. T., Schiffer, C., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Deininger, M. W., Guilhot, F., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0776-2 · Cited by 1,547
Self-citationMarin, D., Bazeos, A., Mahon, F.-X., Eliasson, L., Milojkovic, D., Bua, M., Apperley, J. F., Szydlo, R., Desai, R., Kozlowski, K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3087 · Cited by 909
Self-citation
Metadata
- Authors
- Baccarani, M., Cortes, J., Pane, F., Niederwieser, D., Saglio, G., Apperley, J., Cervantes, F., Deininger, M., Gratwohl, A., Guilhot, F., Hochhaus, A., Horowitz, M., Hughes, T., Kantarjian, H., Larson, R., Radich, J., Simonsson, B., Silver, R. T., Goldman, J., & Hehlmann, R.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-12-10
- Volume
- 27
- Issue
- 35
- Pages
- 6041-6051
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2166654361
- Cited by
- 1,291
- References
- 156
- FWCI
- 92.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.